About This Educational Activity

Title: You and Mesothelioma – An Animated Patient's Guide to Mesothelioma
Launch date: August 20, 2026

This educational activity has been designed to meet the educational needs of patients and caregivers affected by mesothelioma.

This educational activity has been developed by Mesothelioma Applied Research Foundation and Mechanisms in Medicine Inc.

Support: This activity has been funded by generous supporters of the Mesothelioma Applied Research Foundation.

This website is part of the Animated Patient^® series developed by Mechanisms in Medicine Inc., to provide highly visual formats of learning for patients to improve their understanding, make informed decisions, and partner with their healthcare professionals for optimal outcomes.

Faculty:

Dr. Raphael Bueno, MD
Fredric G. Levin Distinguished Professor of Thoracic Surgery and Lung Cancer Research
Brigham and Women's Hospital
Lawrence H. Cohn Professor of Surgery in the field of Cardiothoracic Surgery
Harvard Medical School
Boston, Massachusetts, USA

Dr. Hedy Lee Kindler, MD
Professor of Medicine, Section of Hematology/Oncology
Associate Dean for Clinical Science Research, Human Subjects
The University of Chicago, Biological Sciences Division
Chicago, Illinois, USA

Conflict of Interest Disclosures:

Mechanisms in Medicine Inc. is committed to providing its learners with high quality educational activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this educational activity:

Dr. Raphael Bueno, MD – Patents/Equity: Navigation Sciences; Consulting: Regeneron, Covidien/Medtronic, DiNAQOR, Helios Cardio; Industry Support: Verastem, Genentech, Roche, Myriad Genetics, Novartis, Siemens, Gritstone, Epizyme, MedGenome, Merck, Bicycle Therapeutics, Bayer, Intuitive Surgical, Northpond, Early, ZagBio, NCI, NIH, DoD, NIBIB, NHLBI
Dr. Hedy Lee Kindler, MD – Consulting/Advisory Role: Amgen, Enlaza, Opna Bio, AstraZeneca; Research Funding: AstraZeneca (Inst), Merck (Inst), Bristol Myers Squibb (Inst), Polaris (Inst), Inhibrx (Inst), Roche/Genentech (Inst), Vivace Therapeutics (Inst), Constellation Pharmaceuticals (Inst), Harpoon therapeutics (Inst), Bayer (Inst), Novartis (Inst), CRISPR Therapeutics (Inst)

Disclaimer:

Participants have an implied responsibility to use the newly acquired information to enhance their own personal development.

The information presented in this activity is not meant to serve as a guideline for patient management.
Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should be discussed with your physician.

Technical Requirements:

YouAndMesothelioma.org is an internet-based educational program available on Mac and PC. Click here to view Technical Requirements

This educational activity has been developed by Mesothelioma Applied Research Foundation and Mechanisms in Medicine Inc.

This activity has been funded by generous supporters of the Mesothelioma Applied Research Foundation.

Thank you to the funders of You And Mesothelioma. All content is developed independently by Mesothelioma Applied Research Foundation and Mechanisms in Medicine Inc., in collaboration with an Expert Faculty group; funders are allowed no influence on the content of You And Mesothelioma: An Animated Patient^® Guide to Mesothelioma.

Disclaimer: The information provided is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always consult your doctor about any questions you may have regarding a medical condition. The visuals provided are meant to be representations only. No specific brand is being promoted or endorsed.

This website is part of the Animated Patient^® series developed by Mechanisms in Medicine Inc., to provide highly visual formats of learning for patients to improve their understanding, make informed decisions, and partner with their healthcare professionals for optimal outcomes.